Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-28 @ 3:58 PM
Study NCT ID:
NCT01195766
Status:
COMPLETED
Last Update Posted:
2016-02-24
First Post:
2010-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma
Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
O-ESHAP-LH-2009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None